Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 9th January 2023
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BC Partners prepares sale of VetPartners
BC Partners has appointed JP Morgan and Jefferies to oversee the deal.
The buyout company acquired the group in 2018. 

Private equity firm BC Partners is preparing to sell VetPartners in a deal that could be worth more than £3bn, according to a report by Sky News.

The report states that an auction will take place later this year, and that BC Partners has appointed two banks, JP Morgan and Jefferies, to oversee the process.

CVC Capital Partners, which has a stake in Medivet, is reported to be one of a considerable number of buyout firms already preparing bids for the company.

Established by CEO Jo Malone in October 2015, VetPartners employs some 7,500 employees at 500 sites across the UK and from its York headquarters.

The firm expanded into mainland Europe in 2019 with the purchase of four small animal practices in Italy. It has since bought practices in France, Spain, Portugal, Germany and Ireland.

VetPartners was acquired by BC Partners in 2018 for £700 million.

BC Partners has been contacted for comment.

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.